Seeking Windows of Opportunity to Shape Lifelong Immune Health: A Network-Based Strategy to Predict and Prioritize Markers of Early Life Immune Modulation.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 10 12 2019
accepted: 20 03 2020
entrez: 5 5 2020
pubmed: 5 5 2020
medline: 30 3 2021
Statut: epublish

Résumé

A healthy immune status is strongly conditioned during early life stages. Insights into the molecular drivers of early life immune development and function are prerequisite to identify strategies to enhance immune health. Even though several starting points for targeted immune modulation have been identified and are being developed into prophylactic or therapeutic approaches, there is no regulatory guidance on how to assess the risk and benefit balance of such interventions. Six early life immune causal networks, each compromising a different time period in early life (the 1st, 2nd, 3rd trimester of gestations, birth, newborn, and infant period), were generated. Thereto information was extracted and structured from early life literature using the automated text mining and machine learning tool: Integrated Network and Dynamical Reasoning Assembler (INDRA). The tool identified relevant entities (e.g., genes/proteins/metabolites/processes/diseases), extracted causal relationships among these entities, and assembled them into early life-immune causal networks. These causal early life immune networks were denoised using GeneMania, enriched with data from the gene-disease association database DisGeNET and Gene Ontology resource tools (GO/GO-SLIM), inferred missing relationships and added expert knowledge to generate information-dense early life immune networks. Analysis of the six early life immune networks by PageRank, not only confirmed the central role of the "commonly used immune markers" (e.g., chemokines, interleukins,

Identifiants

pubmed: 32362896
doi: 10.3389/fimmu.2020.00644
pmc: PMC7182036
doi:

Substances chimiques

Biomarkers 0
Chemokines 0
FOXP3 protein, human 0
Forkhead Transcription Factors 0
Cytochrome P-450 CYP1A2 EC 1.14.14.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

644

Informations de copyright

Copyright © 2020 van Bilsen, Dulos, van Stee, Meima, Rouhani Rankouhi, Neergaard Jacobsen, Staudt Kvistgaard, Garthoff, Knippels, Knipping, Houben, Verschuren, Meijerink and Krishnan.

Références

Immunity. 2017 Mar 21;46(3):350-363
pubmed: 28329702
J Bacteriol. 1996 Sep;178(18):5447-51
pubmed: 8808934
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W77-83
pubmed: 23703215
Mol Microbiol. 2010 Sep;77(5):1123-35
pubmed: 20636328
Nat Commun. 2018 Sep 25;9(1):3903
pubmed: 30254319
Br J Nutr. 2015 Oct 14;114(7):999-1012
pubmed: 26228057
Annu Rev Immunol. 2007;25:821-52
pubmed: 17201677
Physiol Rev. 2014 Oct;94(4):1027-76
pubmed: 25287859
Cell. 2018 Aug 23;174(5):1277-1292.e14
pubmed: 30142345
PLoS One. 2012;7(11):e49634
pubmed: 23185389
PLoS One. 2011;6(6):e20284
pubmed: 21695124
Reprod Toxicol. 2016 Sep;64:180-90
pubmed: 27282947
Hepatology. 2009 Oct;50(4):1094-104
pubmed: 19637282
Front Immunol. 2019 Feb 15;10:231
pubmed: 30828334
Hum Gene Ther. 2002 Jul 20;13(11):1383-90
pubmed: 12162820
Med Sci (Basel). 2018 Jul 17;6(3):
pubmed: 30018263
J Leukoc Biol. 2013 Feb;93(2):175-84
pubmed: 23233729
J Reprod Immunol. 2020 Feb;137:102618
pubmed: 31698104
J Virol. 2014 Jul;88(13):7331-44
pubmed: 24741090
Nat Biotechnol. 2005 Oct;23(10):1243-7
pubmed: 16211067
Curr Opin Allergy Clin Immunol. 2014 Oct;14(5):390-6
pubmed: 25102107
Cell Adh Migr. 2015;9(4):317-24
pubmed: 26241004
J Clin Immunol. 2003 May;23(3):147-61
pubmed: 12797537
Nat Immunol. 2003 Jan;4(1):78-86
pubmed: 12447360
Front Immunol. 2017 Dec 11;8:1764
pubmed: 29375543
Mol Syst Biol. 2017 Nov 24;13(11):954
pubmed: 29175850
PLoS Pathog. 2013;9(5):e1003258
pubmed: 23696729
Cell. 1997 May 16;89(4):587-96
pubmed: 9160750
J Comput Biol. 2014 Jun;21(6):456-65
pubmed: 24665902
Eur J Immunol. 2015 Sep;45(9):2582-92
pubmed: 26046326
Front Immunol. 2017 Jul 10;8:788
pubmed: 28740492
Mech Dev. 2003 Nov;120(11):1351-83
pubmed: 14623443
Healthcare (Basel). 2017 Mar 08;5(1):
pubmed: 28282852
Cell. 2000 Mar 17;100(6):655-69
pubmed: 10761931
Science. 2005 Jan 21;307(5708):430-3
pubmed: 15662016
PLoS One. 2013;8(1):e54204
pubmed: 23382878
Cell Mol Immunol. 2014 Sep;11(5):438-48
pubmed: 25109684
Br J Nutr. 2010 Jul;104 Suppl 1:S1-25
pubmed: 20929595
Mol Syst Biol. 2009;5:290
pubmed: 19638971
Genome Med. 2018 Nov 23;10(1):88
pubmed: 30470248
J Am Acad Dermatol. 2007 Jul;57(1):116-9
pubmed: 17499388
Nat Rev Immunol. 2018 Jun;18(6):374-389
pubmed: 29581532
Psychol Sci. 2007 Dec;18(12):1069-76
pubmed: 18031414
Cell. 2016 May 5;165(4):842-53
pubmed: 27133167
Trends Immunol. 2015 Nov;36(11):684-696
pubmed: 26497259

Auteurs

Jolanda H M van Bilsen (JHM)

Netherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.

Remon Dulos (R)

Netherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.

Mariël F van Stee (MF)

Netherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.

Marie Y Meima (MY)

Netherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.

Tanja Rouhani Rankouhi (T)

Netherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.

Lotte Neergaard Jacobsen (L)

Arla Foods Ingredients, Aarhus, Denmark.

Anne Staudt Kvistgaard (A)

Arla Foods Ingredients, Aarhus, Denmark.

Jossie A Garthoff (JA)

Danone Food Safety Center, Utrecht, Netherlands.

Léon M J Knippels (LMJ)

Danone Nutricia Research, Utrecht, Netherlands.
Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.

Karen Knipping (K)

Danone Nutricia Research, Utrecht, Netherlands.
Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.

Geert F Houben (GF)

Netherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.

Lars Verschuren (L)

Netherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.

Marjolein Meijerink (M)

Netherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.

Shaji Krishnan (S)

Netherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH